Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Weng, Hui ^a   Deng, Yunhua ^a   Xie, Yuyan ^b   Liu, Hongbo ^a   Gong, Feili ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

HMGB1; NF B; Precancerous lesions; Seborrheic keratosis; Squamous cell carcinoma; TLR4

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

ARTICLE; BASAL CELL CARCINOMA; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; PRECANCER; PROTEIN EXPRESSION; SEBORRHEIC KERATOSIS; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL MEMBRANE; CELL NUCLEUS; EXTRACELLULAR SPACE; HMGB1 PROTEIN; HUMANS; KERATOSIS, SEBORRHEIC; PRECANCEROUS CONDITIONS; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

EID: 84879440776     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-311     Document Type: Article

References (40)

1. Barta P, Van Pelt C, Men T, Dickey BF, Lotan R, Moghaddam SJ. Enhancement of lung tumorigenesis in a Gprc5a knockout mouse by chronic extrinsic airway inflammation. Mol Cancer 2012, 11:4. 10.1186/1476-4598-11-4, 3281775, 22239913.
2. Kyewski B, Romero P. Chronic inflammation is regarded as a strong promoter of tumorigenesis. Int J Cancer 2010, 127(4):747.
3. Carothers AM, Davids JS, Damas BC, Bertagnolli MM. Persistent cyclooxygenase-2 inhibition downregulates NF-{kappa}B, resulting in chronic intestinal inflammation in the min/+ mouse model of colon tumorigenesis. Cancer Res 2010, 70(11):4433-4442. 10.1158/0008-5472.CAN-09-4289, 3242378, 20484034.
4. Jube S, Rivera Z, Bianchi ME, Powers A, Wang E, Pagano IS, Pass HI, Gaudino G, Carbone M, Yang H. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Res 2012, 72(13):3290-3301. 10.1158/0008-5472.CAN-11-3481, 22552293.
5. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007, 81(1):1-5.
6. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 And RAGE in inflammation and cancer. Annu Rev Immunol 2010, 28:367-388. 10.1146/annurev.immunol.021908.132603, 20192808.
7. Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M, Dumitriu IE, Muller S, Iannacone M, Traversari C, et al. HMGB1 Is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004, 5(8):825-830. 10.1038/sj.embor.7400205, 1299116, 15272298.
8. Dai S, Sodhi C, Cetin S, Richardson W, Branca M, Neal MD, Prindle T, Ma C, Shapiro RA, Li B, et al. Extracellular high mobility group box-1 (HMGB1) inhibits enterocyte migration via activation of toll-like receptor-4 and increased cell-matrix adhesiveness. J Biol Chem 2010, 285(7):4995-5002. 10.1074/jbc.M109.067454, 2836103, 20007974.
9. Akaike H, Kono K, Sugai H, Takahashi A, Mimura K, Kawaguchi Y, Fujii H. Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer. Anticancer Res 2007, 27(1A):449-457.
10. Ellerman JE, Brown CK, De Vera M, Zeh HJ, Billiar T, Rubartelli A, Lotze MT. Masquerader: high mobility group box-1 and cancer. Clin Cancer Res 2007, 13(10):2836-2848. 10.1158/1078-0432.CCR-06-1953, 17504981.
11. Tadie JM, Bae HB, Deshane JS, Bell CP, Lazarowski ER, Chaplin DD, Thannickal VJ, Abraham E, Zmijewski JW. TLR4 Engagement inhibits AMPK activation through a HMGB1 dependent mechanism. Mol Med 2012, 9(18):659-668.
12. Naugler WE, Karin M. NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 2008, 18(1):19-26. 10.1016/j.gde.2008.01.020, 2587362, 18440219.
13. Tang D, Kang R, Zeh HJ, Lotze MT. High-mobility group box 1 and cancer. Biochim Biophys Acta 2010, 1799(1-2):131-140. 2818552, 20123075.
14. Liu PL, Tsai JR, Hwang JJ, Chou SH, Cheng YJ, Lin FY, Chen YL, Hung CY, Chen WC, Chen YH, et al. High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness. Am J Respir Cell Mol Biol 2010, 43(5):530-538. 10.1165/rcmb.2009-0269OC, 19933377.
15. Pacifico F, Leonardi A. NF-kappaB in solid tumors. Biochem Pharmacol 2006, 72(9):1142-1152. 10.1016/j.bcp.2006.07.032, 16956585.
16. Peek RM, Fiske C, Wilson KT. Role of innate immunity in helicobacter pylori-induced gastric malignancy. Physiol Rev 2010, 90(3):831-858. 10.1152/physrev.00039.2009, 2990353, 20664074.
17. Ito Y, Bhawal UK, Sasahira T, Toyama T, Sato T, Matsuda D, Nishikiori H, Kobayashi M, Sugiyama M, Hamada N, et al. Involvement of HMGB1 and RAGE in IL-1beta-induced gingival inflammation. Arch Oral Biol 2012, 57(1):73-80. 10.1016/j.archoralbio.2011.08.001, 21861984.
18. Agresti A, Lupo R, Bianchi ME, Muller S. HMGB1 Interacts differentially with members of the Rel family of transcription factors. Biochem Biophys Res Commun 2003, 302(2):421-426. 10.1016/S0006-291X(03)00184-0, 12604365.
19. Kim SW, Lim CM, Kim JB, Shin JH, Lee S, Lee M, Lee JK. Extracellular HMGB1 released by NMDA treatment confers neuronal apoptosis via RAGE-p38 MAPK/ERK signaling pathway. Neurotox Res 2011, 20(2):159-169. 10.1007/s12640-010-9231-x, 21116767.
20. Nogueira-Machado JA, Volpe CM, Veloso CA, Chaves MM. HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation. Expert Opin Ther Targets 2011, 15(8):1023-1035. 10.1517/14728222.2011.575360, 21585289.
21. Andersson U, Rauvala H. Introduction: HMGB1 in inflammation and innate immunity. J Intern Med 2011, 270(4):296-300. 10.1111/j.1365-2796.2011.02430.x, 21793949.
22. Vitali R, Stronati L, Negroni A, Di Nardo G, Pierdomenico M, Del Giudice E, Rossi P, Cucchiara S. Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease. Am J Gastroenterol 2011, 106(11):2029-2040. 10.1038/ajg.2011.231, 21788990.
23. Hashimoto C, Hudson KL, Anderson KV. The toll gene of drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 1988, 52(2):269-279. 10.1016/0092-8674(88)90516-8, 2449285.
24. Wu B, Huan T, Gong J, Zhou P, Bai Z. Domain combination of the vertebrate-like TLR gene family: implications for their origin and evolution. J Genet 2011, 90(3):401-408. 10.1007/s12041-011-0097-3, 22227927.
25. Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004, 5(10):975-979. 10.1038/ni1116, 15454920.
26. Pandey SC. TLR4-MyD88 Signalling: a molecular target for alcohol actions. Br J Pharmacol 2012, 165(5):1316-1318. 10.1111/j.1476-5381.2011.01695.x, 3372717, 21955082.
27. Bauerfeld CP, Rastogi R, Pirockinaite G, Lee I, Huttemann M, Monks B, Birnbaum MJ, Franchi L, Nunez G, Samavati L. TLR4-Mediated AKT activation is MyD88/TRIF dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor a in murine macrophages. J Immunol 2012, 188(6):2847-2857. 10.4049/jimmunol.1102157, 3294201, 22312125.
28. Hirano H, Yoshioka T, Yunoue S, Fujio S, Yonezawa H, Niiro T, Habu M, Oyoshi T, Sugata S, Kamezawa T, et al. TLR4, IL-6, IL-18, MyD88 and HMGB1 are highly expressed in intracranial inflammatory lesions and the IgG4/IgG ratio correlates with TLR4 and IL-6. Neuropathology 2012, 32(6):628-637. 10.1111/j.1440-1789.2012.01310.x, 22414145.
29. Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 2008, 8(11):837-848. 10.1038/nri2423, 18927578.
30. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005, 5(10):749-759. 10.1038/nri1703, 16175180.
31. Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-kappaB signaling pathways. Nat Immunol 2011, 12(8):695-708. 10.1038/ni.2065, 21772278.
32. Siggers T, Chang AB, Teixeira A, Wong D, Williams KJ, Ahmed B, Ragoussis J, Udalova IA, Smale ST, Bulyk ML. Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-kappaB family DNA binding. Nat Immunol 2012, 13(1):95-102.
33. Espinosa L, Bigas A, Mulero MC. Alternative nuclear functions for NF-kappaB family members. Am J Cancer Res 2011, 1(4):446-459. 3186045, 21984965.
34. Yadav VR, Prasad S, Gupta SC, Sung B, Phatak SS, Zhang S, Aggarwal BB. 3-Formylchromone interacts with cysteine 38 in p65 protein and with cysteine 179 in IkappaBalpha kinase, leading to down-regulation of nuclear factor-kappaB (NF-kappaB)-regulated gene products and sensitization of tumor cells. J Biol Chem 2012, 287(1):245-256. 10.1074/jbc.M111.274613, 3249075, 22065587.
35. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996, 87(1):13-20. 10.1016/S0092-8674(00)81318-5, 8858144.
36. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986, 46(5):705-716. 10.1016/0092-8674(86)90346-6, 3091258.
37. Ohtsuka K, Hata M. Molecular chaperone function of mammalian Hsp70 and Hsp40-a review. Int J Hyperthermia 2000, 16(3):231-245. 10.1080/026567300285259, 10830586.
38. Tsan MF, Gao B. Heat shock proteins and immune system. J Leukoc Biol 2009, 85(6):905-910. 10.1189/jlb.0109005, 19276179.
39. Wallin RP, Lundqvist A, More SH, Von Bonin A, Kiessling R, Ljunggren HG. Heat-shock proteins as activators of the innate immune system. Trends Immunol 2002, 23(3):130-135. 10.1016/S1471-4906(01)02168-8, 11864840.
40. Krause M, Rodrigues-Krause Jda C. Extracellular heat shock proteins (eHSP70) in exercise: possible targets outside the immune system and their role for neurodegenerative disorders treatment. Med Hypotheses 2011, 76(2):286-290. 10.1016/j.mehy.2010.10.025, 21071151.